logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2020 — Atezolizumab plus paclitaxel for mTNBC fails to improve PFS, OS

US FDA issued a warning 2 weeks ago not to use this combination.